Omicron Pharmaceuticals company information, Employees & Contact Information

US agencies flag possible stroke risk with Pfizer, BioNTech bivalent COVID jab FirstWord Pharma

FDA signs off on Lilly's new antibody drug, bebtelovimab, which is effective against the omicron variant Fierce Pharma

Pharma Spammers Use Omicron Variant to Push Fake Diabetes Supplements Bitdefender

Lilly back in COVID-19 antibody game with $720M deal with U.S. for omicron-busting hopeful Fierce Pharma

Moderna says Spikevax booster triggers higher protection against Omicron FirstWord Pharma

Gilead's COVID-19 antiviral Veklury blew past sales estimates in late 2021 as omicron surged, vaccinations lagged Fierce Pharma

Moderna's Omicron-containing COVID-19 booster vaccine tops Spikevax FirstWord Pharma

Celltrion races inhaled COVID-19 antibody therapy into phase 3 to counter omicron Fierce Pharma

Pfizer, AstraZeneca run it back in IDEA Pharma's annual innovation rankings Fierce Pharma

FDA bans Lilly, Regeneron antibody use in COVID-19 patients infected by omicron Fierce Pharma

BioNTech CEO Sahin urges calm amid omicron’s spread, figures new vaccine will eventually be needed for variant Fierce Pharma

As George Scangos bids adieu, Vir taps Bayer dealmaker Marianne De Backer as its next CEO Fierce Pharma

FDA halts use of GlaxoSmithKline and Vir's COVID-19 drug sotrovimab in 8 northeast states Fierce Pharma

Gilead's Veklury expands FDA nod to patients outside the hospital as oral version heads to trial Fierce Pharma

FDA shelves Eli Lilly's COVID antibody bebtelovimab as evasive subvariants take hold Fierce Pharma

Pfizer's deal with Medicines Patent Pool includes 35 companies from 12 countries to produce generic Paxlovid Fierce Pharma

COVID-19 tracker: WHO ends global health emergency Fierce Pharma

Apprentice.io scores $100M funding for augmented reality tech that helped drug plants work through COVID-time Fierce Pharma

The last to fall: FDA nixes emergency nod on AstraZeneca's COVID-19 antibody Evusheld Fierce Pharma

Zydus hit with trio of FDA observations at Indian injectables plant Fierce Pharma

FDA signs off on Modena, Pfizer/BioNTech's adapted vaccines to corral elusive COVID virus Fierce Pharma

Pfizer boosts Paxlovid manufacturing capacity as Merck's rival COVID pill hits surprise efficacy setback Fierce Pharma

Moderna next-gen COVID booster hits the mark in late-stage study FirstWord Pharma

FDA pushes back GC Pharma's blood derivative approval due to inspection delay Fierce Pharma

AstraZeneca reports sales drop for Evusheld. Why is the variant-busting COVID med underachieving? Fierce Pharma

Moderna, hoping to serve an ace with its new booster, taps Billie Jean King for its US Open campaign Fierce Pharma

With 200M unused doses, AstraZeneca's COVID vaccine partner Serum Institute halts production Fierce Pharma

Daiichi Sankyo signs pact to supply 1.4M mRNA COVID vaccine doses in Japan Fierce Pharma

Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck Fierce Pharma

US expects shift to commercial COVID market in potential boon to Pfizer Fierce Pharma

Moderna CEO wants to build plant in Japan pending a long-term vaccine deal: report Fierce Pharma

US okays Invivyd's Pemgarda to guard immunocompromised against COVID FirstWord Pharma

Cost watchdog slashes suggested price of Pfizer's Paxlovid by 80% FirstWord Pharma

Novavax, at long last, clinches FDA emergency nod for protein-based COVID shot Fierce Pharma

Pfizer hikes COVID vaccine sales forecast by $2 billion FirstWord Pharma

UPDATED: Moderna CEO Stéphane Bancel earned $19.4M in 2022 but made much more in stock sales Fierce Pharma

GlaxoSmithKline, Medicago’s plant-based COVID vaccine, Covifenz, wins first approval Fierce Pharma

FDA converts emergency nod for Lilly's Olumiant to a full approval for hospitalized COVID patients Fierce Pharma

COVID-19 tracker: Hetero's generic version of Paxlovid becomes first endorsed by WHO Fierce Pharma

Pfizer gives up on Paxlovid in less vulnerable COVID patients after data fail to impress Fierce Pharma

AstraZeneca's Evusheld becomes first FDA-authorized COVID antibody to protect the immunocompromised before exposure Fierce Pharma

Shionogi's antiviral comes up short in global COVID-19 trial Fierce Pharma

Amgen, AstraZeneca score FDA nod for blockbuster hopeful asthma drug Tezspire Fierce Pharma

With COVID vaccine on the way, Daiichi Sankyo builds Japan's first mRNA plant: report Fierce Pharma

Acturus slides on Phase III COVID-19 vaccine data despite hitting main goal FirstWord Pharma

Arcturus JV scored $115M in Japanese grants to boost mRNA manufacturing Fierce Pharma

Pfizer posts record quarterly sales, driven by Comirnaty, Paxlovid FirstWord Pharma

AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments Fierce Pharma

Novavax slides after FDA flags myocarditis cases tied to COVID-19 vaccine FirstWord Pharma

Merck raises revenue guidance thanks to a surprising bump from COVID-19 pill Lagevrio Fierce Pharma

Pfizer, targeting a younger demographic, enlists yet another celeb for its latest COVID vaccine ad Fierce Pharma

From AstraZeneca to Novavax: Serum Institute wins FDA nod to supply new COVID shot to US from India Fierce Pharma